Today: 9 June 2026
Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus

NEW YORK, Jan 22, 2026, 12:08 PM EST — Regular session

Salesforce (CRM.N) shares climbed roughly 1.7% to $225.25 on Thursday, buoyed by a tech-driven rally in U.S. equities. The stock fluctuated within a range of $221.28 to $226.55.

Salesforce rebounded following a tough stretch. The stock dropped 3.1% on Tuesday, ending the day at $220.07, down roughly 40% from its 52-week peak, according to MarketWatch data.

This is crucial since Salesforce serves as a barometer for major corporate software spending. Investors have slammed cloud stocks at the slightest sign that deal cycles are dragging out. Once risk appetite picks up, shorts and underweight funds tend to react swiftly.

Sentiment lifted after President Donald Trump eased his tariff threat on Europe, with economic data showing steady demand, Reuters reported. “The selloff that we saw had nothing to do with the Sell America trade,” said Elias Haddad, global head of markets strategy at Brown Brothers Harriman. Reuters

Salesforce made news as CEO Marc Benioff called for stricter rules on AI chatbots during the World Economic Forum in Davos. “It can’t be just growth at any cost. There has to be some regulation,” Benioff told CNBC, per SFGATE.

The issue is far from theoretical. Reuters revealed this week that AI hiring platform Eightfold, which counts Salesforce among its clients, faces a lawsuit in California. The suit alleges violations of U.S. credit-reporting laws related to job applicants.

Salesforce, known for its customer-management software, has been promoting “Agentforce,” a new feature that enables clients to deploy AI agents—software designed to process inputs and execute tasks—across various business functions. Reuters

Salesforce was one of the gainers early on, giving the Dow a boost, with Procter & Gamble also playing a key role in lifting the index, MarketWatch reported.

That relief rally might not last. Renewed tariff tensions, changes in rate forecasts, or fresh legal challenges tied to AI tools could drag down pricey software stocks, even without any major company updates.

Next up: earnings. Salesforce hasn’t set a date yet, but MarketBeat projects results will drop Feb. 25 after the market closes. Traders will be zeroed in on guidance and bookings — that’s new contracts signed — for signs of demand heading into the new fiscal year.

Stock Market Today

  • Cotton Futures Hold Steady Amid Mixed Trading and Market Moves
    June 9, 2026, 9:23 AM EDT. Cotton futures showed mixed performance on Monday with 5 to 15 point gains in most contracts, except July which fell 25 points by midday. The US dollar index declined to 99.94, while crude oil prices rose by 79 cents. Weekly Commodity Futures Trading Commission (CFTC) data revealed speculative funds reduced their net long positions in cotton by 1,798 contracts to 52,402 as of June 2. The Seam reported sales of 1,311 bales at 74.00 cents per pound, while the Cotlook A Index dropped 135 points to 86.15 cents on Friday. ICE certified cotton stocks increased by 11,219 bales to 261,648 on June 5. Key futures: July cotton at 73.5 cents (down 25), December 77.59 (up 11), March 78.85 (up 5). This reflects cautious market sentiment amid variable data.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX
Previous Story

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Coinbase stock slips after Base balance glitch; what traders are watching next
Next Story

Coinbase stock slips after Base balance glitch; what traders are watching next

Go toTop